Leah Goodman Joins Providence Therapeutics Board to Enhance mRNA Innovations Providence Therapeutics has appointed Leah Goodman to its Board of Directors, bringing invaluable experience in biotechnology and regulatory affairs to drive innovation.

Leah Goodman Joins Providence Therapeutics Board to Enhance mRNA Innovations #Canada #Calgary #mRNA #Providence_Therapeutics #Leah_Goodman

Revolutionary Pediatric mRNA Cancer Vaccine Trial Begins in Australia Providence Therapeutics launches the first-ever mRNA cancer vaccine trial for children with aggressive brain tumors in Australia, marking a crucial step in pediatric oncology.

Revolutionary Pediatric mRNA Cancer Vaccine Trial Begins in Australia #Canada #Calgary #mRNA_Vaccine #Providence_Therapeutics #PaedNEO-VAX